Activity and safety of brigatinib (BRG) in patients (pts) with ALK+ non–small cell lung cancer (NSCLC): phase (ph) 1/2 trial results Corey J. Langer, Scott N. Gettinger, Lyudmila Bazhenova, Ravi Salgia, Kathryn A. Gold, Rafael Rosell, Alice Tsang Shaw, Glen J. Weiss, David J. Dorer, Victor M. Rivera, Frank G. Haluska, David Kerstein, D. Ross Camidge.
Poster #164989
Activity of brigatinib (BRG) in crizotinib (CRZ) resistant patients (pts) according to ALK mutation status Author(s): Scott N. Gettinger, Sen Zhang, J. Graeme Hodgson, Lyudmila Bazhenova, Sjaak Burgers, Dong-Wan Kim, Daniel Shao-Weng Tan, Han A. Koh, James C. M. Ho, Santiago Viteri Ramirez, Alice Tsang Shaw, Glen J. Weiss, Corey J. Langer, Rudolf M. Huber, Myung-Ju Ahn, William G Reichmann, David Kerstein, Victor M. Rivera, D. Ross Camidge.
Poster #9060
Multi-arm, open-label Phase 1b study of FP-1039/GSK3052230 with chemotherapy in malignant pleural mesothelioma (MPM) Jose Manuel Trigo Perez, Emilie Van Brummelen, Evgeny Levchenko, Manuel Domine, Pilar Garrido Lopez, Hedy L. Kindler, Daniel Morgensztern, Marjorie Glass Zauderer, Johan F. Vansteenkiste, Santiago Viteri Ramirez, Katherine Baker Neblett, Jeffrey Botbyl, Eddie Jose, Adina Zajac, Ionel Mitrica, Robert S. Sikorski, Li Yan.
Poster #8557
Addition of HSP90 inhibitor onalespib to crizotinib prior to progression in patients with ALK-pos NSCLC: Results of a randomized phase 2 study Jong-Seok Lee, Ji-Youn Han, Myung-Ju Ahn, In-Jae Oh, HyeRyun Kim, Dae Ho Lee, Erin Marie Bertino, Santiago Viteri Ramirez, Nathan A. Pennell, Antoinette J. Wozniak, Joan H. Schiller, Chester Lin, Harold N. Keer, Mohammad Azab, Benjamin Besse, D. Ross Camidge.
Poster #9059
Selective CHK1 inhibition as a therapeutic approach in NSCLC, a new option for KRAS mutated patients and squamous cell carcinoma Daniela Morales-Espinosa, Silvia García-Román, Miguel Angel Molina-Vila, Ana Gimenez Capitan, Jordi Bertran-Alamillo, Pedro Mendez, Santiago Viteri Ramirez, Niki Karachaliou, Rafael Rosell.
Poster #169740
EGFR mutant cfDNA and CTC detection as biomarkers in patients diagnosed with advanced non-small cell lung cancer Silvia Calabuig-Fariñas, Eloisa Jantus-Lewintre, Clara Mayo-de las Casas, Nuria Jordana-Ariza, Ariadna Balada, Ana Blasco, Miguel Angel Molina-Vila, Rafael Rosell, Carlos Camps.
Proceedings #169534
